USPTO serial 76251022
Serial No. 76251022
Reviewed by CopyMark Law Group
Reg. 2993571Status 710
- Filing date
- Status date
- Registration date
- Sep 13, 2005
- Examiner
- BUSH, KAREN K
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with Serial No. 76251022?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Leeds LS2 9XT, GB
Leeds LS2 9XT, GB
Leeds LS2 9XT, GB
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kristen N. Goodman
MICHELLE L VISSER RADER, FISHMAN & GRAUER PLLC39533 WOODWARD AVE STE 140BLOOMFIELD HILLS, MI 48304UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Enzymes for non-medical applications, namely, enzymes for scientific and medical research use; Polymerases, transcriptases and replicons for non-medical applications, namely, polymerases, transcriptases and replicons for scientific and medical research use; Kits consisting primarily of reagents for scientific and medical research use for detecting and monitoring the activity of enzymes, transcriptases and polymerases | SECTION 8 - CANCELLED | — |
| 005 | Pharmaceutical and veterinary preparations in the nature of anti-infective agents; Enzymes for medical application in the nature of clinical medical reagents, diagnostic reagents for clinical and medical laboratory use, medical diagnostic reagents, reagents for invitro use in biochemistry, enzymes for clinical chemistry and microbiology, reagents for clinical or medical laboratory use; Polymerases, transcriptases and replicons for medical application in the nature of clinical medical reagents, diagnostic reagents for clinical and medical laboratory use, medical diagnostic reagents, reagents for in vitro use in biochemistry, enzymes for clinical chemistry and microbiology, reagents for clinical and medical laboratory use | SECTION 8 - CANCELLED | — |
| 009 | Scientific apparatus and instrumentation in the nature of laboratory equipment for compound screening, namely, microtitre plate readers, microtitre plate washers, pipettes, vials and microtitre plates, all for scientific purposes; Kits consisting primarily of scientific apparatus and instrumentation in the nature of laboratory equipment, namely, microtitre plate readers, microtitre plate washers, pipettes, vials, and a coated microtitre plate to serve as a surface for reactions to take place, for use in the field of science and medicine; Kits consisting primarily of scientific apparatus and instrumentation in the nature of laboratory equipment for compound screening, namely, microtitre plate readers, microtitre plate washers, pipettes, vials, and a coated microtitre plate to serve as a surface for reactions to take place, for detecting and monitoring the activity of enzymes, transcriptases and polymerases for scientific, medical and veterinary research use; Kits consisting primarily of scientific apparatus and instrumentation in the nature of laboratory equipment, namely, microtitre plate readers, microtitre plate washers, pipettes, vials, and a coated microtitre plate to serve as a surface for reactions to take place, for compound screening and detecting and monitoring the activity of transcriptases and polymerases; Computer programs for use in database management, for use as a spread sheet, or for word processing all for use in the field of science and medicine; Downloadable electronic publications in the nature of press releases, journal articles, books, reports, protocol guides and books, and instructional material provided online from databases such as the Internet in the field of science and medicine; Computer software to enable the searching of data in the field of science and medicine | SECTION 8 - CANCELLED | — |
| 010 | Medical and veterinary apparatus in the nature of an immunodiagnostic test apparatus for medically examining the activity of enzymes, transcriptases and polymerases; Kits consisting primarily of a coated microtitre plate to serve as a surface for reactions to take place, for detecting and monitoring the activity of enzymes, transcriptases and polymerases and medical reagents and diagnostic reagents for medically examining the activity of enzymes, transcriptases and polymerases | SECTION 8 - CANCELLED | — |
| 016 | Printed matter of a scientific or medical nature, namely, press releases, journal articles, reports, protocol guides and books, and instructional material; Printed publications of a scientific or medical nature, namely, press releases, journal articles, reports, protocol guides and books, and instructional material; Printed instructional and teaching material of a scientific or medical nature; Data recorded in paper form from the Internet, namely, press releases, journal articles, reports, protocol guides and books, and instructional material all of a scientific or medical nature; Packaging in the nature of boxes, cartons and paper for wrapping and packaging; Photographs; and Posters | SECTION 8 - CANCELLED | — |
| 041 | Educational services namely conducting classes, seminars, workshops, conferences and distributing course material in the field of science and medicine; Providing training in the field of assay technology | SECTION 8 - CANCELLED | — |
| 042 | Medical and veterinary services; Scientific and industrial research services; Pharmaceutical research and development in the nature of compound screening services; Design of pharmaceutical drugs for others; Pharmaceutical research and development in the nature of pharmaceutical compound screening services; Design of pharmaceutical drugs for others; Pharmaceutical research and development in the nature of assay development services; Pharmaceutical and medical diagnostic services; Scientific research in the nature of monitoring of polymerase activity; Scientific research in the nature of monitoring of transcriptase activity | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Replizyme Limited
- Other trademarks owned by Replizyme Limited
- Other trademarks owned by Replizyme Limited
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 016
- Other trademarks in Class 041
- Other trademarks in Class 042
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 21, 2012 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Sep 13, 2005 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 21, 2005 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 1, 2005 | NPUB | NOTICE OF PUBLICATION | — |
| Mar 7, 2005 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Feb 7, 2005 | ALIE | ASSIGNED TO LIE | — |
| Feb 1, 2005 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 1, 2005 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Nov 18, 2004 | ADBS | 1(B) BASIS DELETED; NEW BASIS REQUESTED | — |
| Sep 28, 2004 | PCGR | PETITION TO DIRECTOR GRANTED | — |
| Aug 25, 2004 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 13, 2004 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| Jul 2, 2004 | PCRC | PETITION TO DIRECTOR RECEIVED | — |
| Jul 2, 2004 | PAPER RECEIVED | — | |
| Jun 17, 2004 | CFIT | CASE FILE IN TICRS | — |
| Feb 10, 2004 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 13, 2004 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Oct 21, 2003 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 1, 2003 | NPUB | NOTICE OF PUBLICATION | — |
| Jul 30, 2003 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 19, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 19, 2003 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 15, 2003 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 9, 2003 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 9, 2003 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 9, 2003 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 20, 2003 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 12, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 12, 2003 | PAPER RECEIVED | — | |
| Aug 13, 2002 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 5, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 5, 2002 | PAPER RECEIVED | — | |
| Jun 6, 2002 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Feb 8, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 10, 2001 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 30, 2001 | DOCK | ASSIGNED TO EXAMINER | — |